183 related articles for article (PubMed ID: 11997076)
1. Human venous and arterial glycosaminoglycans have similar affinity for plasma low-density lipoproteins.
Leta GC; Mourão PA; Tovar AM
Biochim Biophys Acta; 2002 Apr; 1586(3):243-53. PubMed ID: 11997076
[TBL] [Abstract][Full Text] [Related]
2. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL.
Cardoso LE; Mourão PA
Arterioscler Thromb; 1994 Jan; 14(1):115-24. PubMed ID: 8274466
[TBL] [Abstract][Full Text] [Related]
3. Age-related changes in populations of aortic glycosaminoglycans: species with low affinity for plasma low-density lipoproteins, and not species with high affinity, are preferentially affected.
Tovar AM; Cesar DC; Leta GC; Mourão PA
Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):604-14. PubMed ID: 9580254
[TBL] [Abstract][Full Text] [Related]
4. Interaction of high molecular weight chondroitin sulfate from human aorta with plasma low density lipoproteins.
Alves CS; Mourão PA
Atherosclerosis; 1988 Oct; 73(2-3):113-24. PubMed ID: 3142491
[TBL] [Abstract][Full Text] [Related]
5. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction.
Srinivasan SR; Vijayagopal P; Eberle K; Radhakrishnamurthy B; Berenson GS
Biochim Biophys Acta; 1989 Nov; 1006(2):159-66. PubMed ID: 2512982
[TBL] [Abstract][Full Text] [Related]
7. The binding of human aortic glycosaminoglycans and proteoglycans to plasma low density lipoproteins.
Mourão PA; Bracamonte CA
Atherosclerosis; 1984 Feb; 50(2):133-46. PubMed ID: 6712767
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycan distribution in atherosclerotic saphenous vein grafts.
Marquezini MV; Strunz CM; Dallan LA; Toledo OM
Cardiology; 1995; 86(2):143-6. PubMed ID: 7728804
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein binding affinity of arterial chondroitin sulfate proteoglycan variants modulates cholesteryl ester accumulation in macrophages.
Srinivasan SR; Xu JH; Vijayagopal P; Radhakrishnamurthy B; Berenson GS
Biochim Biophys Acta; 1995 Aug; 1272(1):61-7. PubMed ID: 7662721
[TBL] [Abstract][Full Text] [Related]
10. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
[TBL] [Abstract][Full Text] [Related]
11. The binding of chondroitin 6-sulfate to plasma low density lipoprotein.
Mourão PA; Pillai S; Di Ferrante N
Biochim Biophys Acta; 1981 May; 674(2):178-87. PubMed ID: 6786361
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of low-density lipoprotein interaction with glycosaminoglycans.
Gigli M; Ghiselli G; Torri G; Naggi A; Rizzo V
Biochim Biophys Acta; 1993 Apr; 1167(2):211-7. PubMed ID: 8466951
[TBL] [Abstract][Full Text] [Related]
13. Plasma low density lipoprotein accumulation in aortas of hypercholesterolemic swine correlates with modifications in aortic glycosaminoglycan composition.
Hoff HF; Wagner WD
Atherosclerosis; 1986 Sep; 61(3):231-6. PubMed ID: 3094551
[TBL] [Abstract][Full Text] [Related]
14. Specificity of the low density lipoprotein-glycosaminoglycan interaction.
Sambandam T; Baker JR; Christner JE; Ekborg SL
Arterioscler Thromb; 1991; 11(3):561-8. PubMed ID: 2029496
[TBL] [Abstract][Full Text] [Related]
15. Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity.
Sartipy P; Johansen B; Camejo G; Rosengren B; Bondjers G; Hurt-Camejo E
J Biol Chem; 1996 Oct; 271(42):26307-14. PubMed ID: 8824283
[TBL] [Abstract][Full Text] [Related]
16. Fractionation of heparin, dermatan sulfate, and chondroitin sulfate by sequential precipitation: a method to purify a single glycosaminoglycan species from a mixture.
Volpi N
Anal Biochem; 1994 May; 218(2):382-91. PubMed ID: 8074297
[TBL] [Abstract][Full Text] [Related]
17. High hyaluronic acid and low dermatan sulfate contents in human pulmonary arteries compared to in the aorta.
Murata K; Yokoyama Y
Blood Vessels; 1988; 25(1):1-11. PubMed ID: 3334901
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycans from renal brush border membranes of rabbits.
Munakata H; Isemura M; Aikawa J; Kodama C; Yosizawa Z
Tohoku J Exp Med; 1985 Apr; 145(4):353-8. PubMed ID: 3927514
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycan-degrading enzymes in the varicose vein wall.
Kowalewski R; Sobolewski K; Malkowski A; Gacko M; Rutkowska I
Int Angiol; 2008 Dec; 27(6):529-35. PubMed ID: 19078917
[TBL] [Abstract][Full Text] [Related]
20. Cerebral atherosclerosis in Japanese part 6: the interaction of plasma lipoproteins with glycosaminoglycans isolated from the cerebral arteries and aortas.
Nakashima Y; Nakamura M; Kikuchi Y
Artery; 1981; 9(2):151-5. PubMed ID: 6457588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
